Simoa
Ultra-sensitive biomarker detection · fg/mL to ag/mL
Simoa
연구·임상 통합 워크플로우
고정밀 분석 · 전공정 자동화
엔터프라이즈 Lab 환경 대응 설계
Applications
Overview
Ultra-sensitive single-molecule biomarker detection across all sample types. 1000× more sensitive than conventional ELISA · comprehensive clinical interpretation report.
Key Features
- Ultra-sensitivity
- Multiple sample types
- Comprehensive reporting
- Fast turnaround
Key Performance Metrics
* Based on internal test results
ag/mL Ultra-sensitivity
1000× more sensitive than conventional ELISA—enabling biomarker discovery that was previously impossible
All Sample Types Supported
Equal sensitivity achieved across serum, CSF, urine, and tissue extracts
Comprehensive Clinical Report
Detailed analysis report beyond raw data, including clinical interpretation of findings
Neuro/Immune Marker Specialization
Specialized service for rare markers: blood-brain proteins, ultra-low cytokines, and more
Strategic Advantage
Discover the overwhelming performance advantages over conventional methods and competitors.
| Metrics | Manual | Existing | OUR SOLUTIONSimoa |
|---|---|---|---|
| Detection Sensitivity | Standard ELISA (pg/mL level) | High-sensitivity ELISA (some fg/mL) | Ultra-sensitive fg/mL to ag/mL detection |
| Supported Sample Types | Primarily serum/plasma | 2–3 sample types | Serum, CSF, urine, tissue, and more |
| Analysis Report | Raw data only | Basic statistical analysis included | Comprehensive report with clinical interpretation |
| Rare Biomarker Detection | Cannot detect low-concentration biomarkers | Limited rare marker support | Specialized ultra-low neuro/immune marker detection |
Trusted
Simoa delivers validated performance trusted across research and clinical settings.
Simplifies complex workflows while improving reproducibility and throughput.
Validation
Internal validation data and technical documentation available on request.
Our specialists architect deployment strategies tailored to your environment.